合盛硅業(603260.SH):擬投建年產20萬噸硅氧烷及下游深加工項目 預估總投資逾35億元
格隆匯9月8日丨合盛硅業(603260.SH)公佈,2021年9月8日,公司召開第三屆董事會第七次會議審議通過了《關於全資子公司新疆合盛硅業新材料有限公司對外投資的議案》。
在對有機硅市場充分調研的基礎上,結合公司未來發展戰略規劃,為進一步發揮公司規模優勢和技術優勢,降低生產成本,滿足不斷增長的下游產業需求,保障產業鏈的健康發展,公司擬通過全資子公司新疆合盛硅業新材料有限公司在新疆鄯善縣石材工業園區進行“新疆合盛硅業新材料有限公司煤電硅一體化項目三期年產20萬噸硅氧烷及下游深加工項目”投資建設,項目預估總投資約35.32億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.